Karyopharm Therapeutics Inc (KPTI)
1.04
-0.02
(-1.89%)
USD |
NASDAQ |
Apr 26, 11:03
Karyopharm Therapeutics Total Assets (Quarterly): 240.44M for Dec. 31, 2023
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 240.44M |
| September 30, 2023 | 269.96M |
| June 30, 2023 | 297.83M |
| March 31, 2023 | 325.80M |
| December 31, 2022 | 358.17M |
| September 30, 2022 | 231.24M |
| June 30, 2022 | 256.48M |
| March 31, 2022 | 294.03M |
| December 31, 2021 | 305.30M |
| September 30, 2021 | 254.09M |
| June 30, 2021 | 286.57M |
| March 31, 2021 | 274.91M |
| December 31, 2020 | 313.05M |
| September 30, 2020 | 337.59M |
| June 30, 2020 | 380.01M |
| March 31, 2020 | 416.14M |
| December 31, 2019 | 294.96M |
| September 30, 2019 | 297.74M |
| June 30, 2019 | 238.10M |
| March 31, 2019 | 287.21M |
| December 31, 2018 | 341.19M |
| September 30, 2018 | 219.99M |
| Date | Value |
|---|---|
| June 30, 2018 | 256.59M |
| March 31, 2018 | 146.37M |
| December 31, 2017 | 180.29M |
| September 30, 2017 | 163.77M |
| June 30, 2017 | 185.75M |
| March 31, 2017 | 155.44M |
| December 31, 2016 | 180.38M |
| September 30, 2016 | 183.62M |
| June 30, 2016 | 170.90M |
| March 31, 2016 | 192.14M |
| December 31, 2015 | 215.44M |
| September 30, 2015 | 236.97M |
| June 30, 2015 | 263.29M |
| March 31, 2015 | 292.04M |
| December 31, 2014 | 220.34M |
| September 30, 2014 | 235.16M |
| June 30, 2014 | 137.68M |
| March 31, 2014 | 149.28M |
| December 31, 2013 | 158.23M |
| September 30, 2013 | 55.90M |
| June 30, 2013 | 62.48M |
| December 31, 2012 | 1.311M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
231.24M
Minimum
Sep 2022
416.14M
Maximum
Mar 2020
298.55M
Average
294.96M
Median
Dec 2019
Total Assets (Quarterly) Benchmarks
| Geron Corp | 394.08M |
| Arbutus Biopharma Corp | 144.40M |
| Verastem Inc | 149.72M |
| Actinium Pharmaceuticals Inc | 81.44M |
| Chimerix Inc | 212.77M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 376.64M |
| Shareholders Equity (Quarterly) | -136.21M |
| Debt to Equity Ratio | -1.255 |
| Current Ratio | 3.367 |
| Net Debt Paydown Yield | -0.21% |